Aripiprazole Tablets, USP, 2 mg, 30 Tablets per bottle, Rx only, Manufactured by: Alembic Pharmac...
FDA Drug Recall #D-1341-2020 — Class II — June 10, 2020
Recall Summary
| Recall Number | D-1341-2020 |
| Classification | Class II — Moderate risk |
| Date Initiated | June 10, 2020 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Alembic Pharmaceuticals Limited |
| Location | Tajpura, N/A |
| Product Type | Drugs |
| Quantity | 19,153 bottles |
Product Description
Aripiprazole Tablets, USP, 2 mg, 30 Tablets per bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited (Formulation Division) Panelav 389350, Gujarat, India Manufactured for: Alembic Pharmaceuticals, Inc. 750 Route 202, Bridgewater, NJ 08807 USA, NDC 62332-097-30.
Reason for Recall
Labeling: Label mix up: Bottles labeled as aripiprazole 2 mg, 30 count had aripiprazole 5 mg tablets, 100 count.
Distribution Pattern
Nationwide in the U.S.
Lot / Code Information
Lot: 1905003298 Exp. 01/31/2021
Other Recalls from Alembic Pharmaceuticals Limited
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0248-2026 | Class III | Fesoterodine Fumarate, Extended-release Tablets... | Dec 16, 2025 |
| D-0156-2026 | Class III | Fesoterodine Fumarate, Extended-release Tablets... | Oct 10, 2025 |
| D-0566-2025 | Class II | Doxepin Hydrochloride Capsules, USP, 10 mg, 100... | Jul 25, 2025 |
| D-0459-2025 | Class II | Celecoxib Capsules, 200 mg, 500-count bottle, R... | May 9, 2025 |
| D-0447-2025 | Class II | Bromfenac Ophthalmic Solution 0.09%, 1.7 mL bot... | May 7, 2025 |
Frequently Asked Questions
Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.